the investigators conclude that ( 1 ) pentoxifylline is effective and safe in the treatment of patients with intermittent claudication ( 2 ) the benefits of oral anticoagulant therapy are outweighed by the risk of serious bleeding , and ( 3 ) the risk of bleeding is probably increased by the combined treatment with pentoxifylline .
C0021775
intermittent claudication
C0030899
pentoxifylline